CVS Caremark’s MinuteClinic has become an in-network provider with TriWest, the Western region plan contractor for Tricare — the healthcare insurance program for Uniformed Service members, retirees and their families.
When National Association of Chain Drug Stores president and CEO Steve Anderson earlier this year at NACDS Annual urged pharmacy leaders to be “disruptive innovators,” and new NACDS chairman and Walgreens president and CEO Greg Wasson called on the industry to embrace a holistic view of the total store in improving patient lives, they easily could have submitted Walgreens and its Take Care Health Systems subsidiary as an ideal case study.
Shopkick, a shopping application that rewards shoppers for walking into stores and interacting with products, has teamed up with CVS/pharmacy to roll out a first-ever offering of walk-in and other rewards at a retail pharmacy, Shopkick announced on Tuesday.
In an effort to curb vehicle air pollution, Manhattan-based retailer Duane Reade, which is owned by Walgreens, has teamed up with Mission Electric to create a public outreach campaign to determine which of its stores should be served solely by electric trucks.
AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.
CVS Caremark’s MinuteClinic has announced that it is partnering with Florida Hospital Medical Group, a multispecialty physician group affiliated with Florida Hospital, in a clinical affiliation that expands access to healthcare services in central Florida.
Retail-based clinic operator MinuteClinic, which is owned by CVS Caremark, is partnering with Hackensack University Health Network, the largest provider of inpatient and outpatient health services in New Jersey, in a clinical affiliation that expands access to healthcare services in northeast New Jersey.
The recent loss of business from a key specialty pharmacy customer and the continued deluge of generic introductions will represent significant challenges for Cardinal Health in fiscal year 2013 as it approaches the year-end of its fiscal 2012, company executives told analysts during a conference call Thursday morning.